Natasha Diba Sheybani

University Of Virginia

$2,380,302

Attributed

$2,502,721

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $640.3K · FY2018–25

$1M$750K$500K$250K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,502,721 · 4

By mechanism

DP5$1,994,626 · 1

R21$244,839 · 1

K00$182,623 · 1

F99$80,633 · 1

Top collaborators

Dalia Haydar1 shared

Most similar at University Of Virginia

Same institution · by research overlap

Norbert Leitinger$10,025,679
Monica L Guzman$6,874,300
Li Li$10,636,659
John Hackett Bushweller$17,127,098
Grace C Bingham$257,230

Others in their field

Other Emerging Leaders on “T-Lymphocyte”

Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
Crystal Mackall · Children'S Hosp Of Philadelphia$16,367,876
Wilton B Williams · Duke University$16,226,847
Gary Fanger · Rise Therapeutics, Llc$15,372,982
Aaron Esser-Kahn · University Of Chicago$13,378,548

Research focus

T-LymphocyteRegimenFocused UltrasoundTreatment EfficacyMediatingResponseSolid NeoplasmTumorDesignAcousticsImmunogenicityImmuneImmunotherapyImmunologicsAdaptive ImmunityFoundationsDepositionClinical TrialsDrug Delivery SystemsMentorshipFirst-In-HumanAnti-Tumor Immune ResponseCareerMalignant Breast Neoplasm